AstraZeneca PLC (AZNs)

1,409.91
+27.66(+2.00%)
  • Volume:
    6,011
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    1,409.91 - 1,409.91

AZNs Historical Data

Time Frame:
Daily
07/19/2022 - 08/19/2022
1,409.911,409.911,409.911,409.91+1.45%
1,389.821,391.951,392.751,381.50112.47K+0.75%
1,379.461,370.921,394.501,369.09179.04K-0.02%
1,379.681,379.201,385.001,377.8597.28K+0.32%
1,375.311,378.261,383.501,355.04301.19K+3.58%
1,327.731,315.411,335.001,305.99320.09K+0.29%
1,323.951,294.231,335.001,292.19254.49K-1.13%
1,339.071,340.311,345.271,338.50121.17K+0.02%
1,338.861,327.501,342.501,326.50107.89K+0.56%
1,331.431,348.001,348.001,329.14209.99K-1.08%
1,346.011,337.901,349.501,337.90131.43K+0.78%
1,335.601,331.951,348.001,330.33167.44K-0.20%
1,338.211,330.611,346.091,326.50154.42K+0.38%
1,333.091,349.251,359.471,330.5098.02K-0.05%
1,333.791,346.501,349.071,333.79159.81K-1.13%
1,348.971,325.001,375.501,325.00282.02K-1.25%
1,366.021,359.501,370.501,357.09161.21K-0.76%
1,376.521,376.321,381.581,373.0088.32K-0.33%
1,381.051,367.261,383.501,348.79155.85K+3.15%
1,338.891,341.981,344.411,338.8558.44K+0.20%
1,336.281,334.001,336.311,327.95156.16K+0.49%
1,329.771,342.771,344.501,311.00154.95K-2.53%
1,364.281,386.841,389.621,356.0066.40K+0.63%
1,355.771,380.251,393.001,355.77153.29K-4.30%
Highest: 1,409.91Lowest: 1,292.19Difference: 117.72Average: 1,353.31Change %: -0.48
  • Pfizer and Moderna fell big time in share prices, while Astra kept it’s stable 9ish. How?
    0
    • money to get
      0
    • hello please help you
      0
    • Attila, AZ & Pfizer are pharmaceutical companies that makes medicines. They are not just providers of vaccines. At present, and for the foreseeable future, the AZ science is much stronger than that of Pfizer, and similar to Merck, which is another pharmaceutical company that has grown materially this year. I am long on AZ and Merck.
      0
  • An attractive PRE-IPO called SpectrumX based in England plans to launch by November and i'm very hopeful of this particular investment. Clinical trials for their Covid-19 respiratory treatment are now in phase 2 of development which will be a game changer once hospitals get their hands on it. This will not be factored into the company valuation when listed. So if the trials are successful the market value will rocket. Thats why im seriously excited about this IPO and i don't usually go near PRE IPO's.
    4
    • how's it doing today
      0
    • how's it doing today
      0
  • 50
    0
    • *50000
      0
  • 19970410🌍 10000%
    0
    • Most of vunerable demographic now vaccinated. Will younger people accept the jab or will potential health concerns outweigh the potential benefits. I'm short AstraZeneca
      5
      • net short positions available on the PNC Borsa app
        0
        • Above 7500 to 9750 soon these weeks bullish sentiments business development infrastructure expenditures stimulus package cause its stance growth economics of scales
          2
          • you are nostetadamoos
            1
        • may be buy or sell the stock but be very cautious before being vaccinated : some serious cases in Europe especially with young to intermediate people
          11
          • GP GAPYes Im chief nurse teacher in a very big hospital. Not specialised in vaccine but i know a little bit about heath. And im a pro vaccine. But the rule we were givenby health autorities  was : Astra not for people under 55.
            1
          • Thanks for the advise.
            0
          • Jenny Goughlike dada
            0
        • This is moving now....at last! US approval coming.
          1
          • The cause behind the suspected vaccine side effects has been found. This is the opinion of a Norwegian expert group that examined the three healthcare employees who were admitted to hospital after being vaccinated with Astra Zeneca's vaccine. The vaccine triggered a strong immune reaction in the people. - I see no other reason than that it is the vaccine that triggers it, says the chief physician and professor Pål Andre Holme to VG. Sell off coming
            5
            • I guess that puts this Professor at odds with all the others looking at the data then.   Strange they were all healthcare employees.
              0
            • u shorting?
              1